![The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses | Cellular and Molecular Life Sciences The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses | Cellular and Molecular Life Sciences](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00018-021-04085-1/MediaObjects/18_2021_4085_Fig4_HTML.png)
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses | Cellular and Molecular Life Sciences
![Western Carolinian Volume 52 Number 11, October 30, 1986 | Search | Collections | Southern Appalachian Digital Collections Western Carolinian Volume 52 Number 11, October 30, 1986 | Search | Collections | Southern Appalachian Digital Collections](https://southernappalachiandigitalcollections.org/media/w1000h500/wcu_publications/wcu_publications-12340.jpg)
Western Carolinian Volume 52 Number 11, October 30, 1986 | Search | Collections | Southern Appalachian Digital Collections
Co-IP assay identified MERS-CoV NP as an Hsp90β client protein. 293T... | Download Scientific Diagram
![Frontiers | Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection Frontiers | Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection](https://www.frontiersin.org/files/Articles/721328/fimmu-12-721328-HTML-r1/image_m/fimmu-12-721328-t001.jpg)
Frontiers | Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection
![Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2 | Nature Communications Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2 | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-023-35949-8/MediaObjects/41467_2023_35949_Fig1_HTML.png)
Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2 | Nature Communications
![Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy Methods & Clinical Development Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy Methods & Clinical Development](https://www.cell.com/cms/attachment/86b4af3b-3bee-403b-a44f-a8059cd09389/gr1_lrg.jpg)
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy Methods & Clinical Development
![Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine](https://www.thelancet.com/cms/attachment/7608e228-4ddf-4d90-8763-51e5bbe63e10/gr1_lrg.jpg)
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
Comparative Study of the Mutations Observed in the SARS-CoV-2 RBD Variants of Concern and Their Impact on the Interaction with the ACE2 Protein | The Journal of Physical Chemistry B
![Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/asset/f6ce8544-e326-49cc-815e-3a4c91c5f641/gr1.jpg)
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe
![The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses | Cellular and Molecular Life Sciences The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses | Cellular and Molecular Life Sciences](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00018-021-04085-1/MediaObjects/18_2021_4085_Fig1_HTML.png)
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses | Cellular and Molecular Life Sciences
![Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study - Furuta - 2023 - Transfusion - Wiley Online Library Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study - Furuta - 2023 - Transfusion - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9ed7ea23-8d75-4f5e-b625-9fcd14560a81/trf17382-fig-0003-m.jpg)
Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study - Furuta - 2023 - Transfusion - Wiley Online Library
![Viruses | Free Full-Text | Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron Viruses | Free Full-Text | Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron](https://pub.mdpi-res.com/viruses/viruses-15-00530/article_deploy/html/images/viruses-15-00530-g001a.png?1676520456)